China’s import/export of medical healthcare products was USD 103.4 billion in 2016, a YoY increase of 0.73%, including export of USD 55.4 billion, 1.82% down and import of USD 48billion, 3.83% up, a foreign trade surplus of USD 7.4 billion, 27.3% down. If the exchange rate impact is excluded and RMB is used for calculation, medical foreign trade had an increase of 7.12% in 2016, including 4.41% of export increase and 10.42% of import increase, leading China’s overall foreign trade.

    In 2016, influenced by a number of factors like depressed demand for external main economic entity, under-powered emerging market and increasingly strong price competition, import/export of medical foreign trade entered a low-speed growth period, confronted with difficulties and challenges that shouldn’t be underestimated. In the meantime, we also see medical import/export structure is further improving, corporate internationalization is speeding up and new developing momentum is gathering strength. Overall, medical foreign trade is still advancing for the better.

    Under the strict market conditions, United Lab still manages to make ongoing innovation, maintain a steady growth and become one of the top 100 exporters of medical healthcare products in 2016.